Auxilium Pharma board adopts anti-takeover plan

Published



The board of Auxilium Pharmaceuticals Inc. has adopted a “poison pill” shareholder rights plan to ward off a hostile takeover after Endo International PLC announced an unsolicited offer worth about $1.41 billion for its fellow drugmaker.

Shares of Auxilium soared Wednesday before markets opened and after it said it adopted the one-year plan “to ensure that the (board) remains in the best position to perform its fiduciary duties and to enable all Auxilium stockholders to receive fair and equal treatment.”

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.